CClinicalTrials.gg
CompletedNCT03490071Lund LHGPUpdated Apr 15, 2026

Long-term Follow up of Patients With Longstanding Hip and Groin Pain

An observational study in Hip Pain Chronic, sponsored by Lund University. Completed at 1 site in Sweden. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by Lund University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
58
Ages
18 Years to 55 Years
Sex
All
01

Study summary

In this longitudinal cohort study including young to middle aged people with longstanding hip and groin pain (LHGP) referred to tertiary care, we will collect data of patient reported symptoms, function and quality of life three and seven years after the initial contact with orthopedic surgeon.

Read the detailed description

81 physically active patients (18-55 years) with (LHGP) who were enrolled in a cross-sectional study (Diagnosis and functional limitations in the young to middle-aged physically active population with long-standing hip/groin pain: A cross-sectional study) during the period October 2014 to January 2017 will be recruited to this longitudinal cohort study.

A research coordinator will contact the patients and provide them with written and oral information about the study. Patients who accept to participate will electronically complete the following questionnaires. The same questionnaires were included at baseline, i.e., in the cross-sectional study.

  • Copenhagen Hip and Groin Outcome Score (HAGOS)
  • HSAS - Hip Sports Activity Scale (HSAS)
  • Patient Specific Functional Scale
  • Medical Outcomes Study short form 36 (SF-36)
  • K-10 questionnaire
  • Self-Presentation in Exercise Questionnaire (SPEQ)
  • Multidimensional Scale of Perceived Social Support (MSPSS)

Additional questions about treatment, medication, patient satisfaction and perceived change in hip function will be included.

For descriptive purposes, the mean difference (95% CI), or median (quartiles), between baseline and follow-up assessments will be used as appropriate. Separate linear regression models will be used to evaluate the change in each variable compared to baseline values.

02

Conditions studied

  • Hip Pain Chronic

Keywords

  • Longstanding hip and groin pain
  • Patient reported outcome
03

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients will be recruited from the Department of Orthopedics, Skåne University Hospital, Sweden.

At baseline, the following inclusion and exclusion criteria were used:

Inclusion criteria

Inclusion criteria:

  • Unilateral or bilateral hip/groin pain >3 months
  • Age 18-55 years
  • No previous hip surgery

Exclusion criteria

Exclusion criteria:

  • Hip pathology (i.e., Perthes' disease)
  • Verified moderate or severe osteoarthritis (OA) (Tönnis grade >1)
  • Palpable hernia
  • Low-back pain with a positive Lasègue test
  • MRI-verified lower back/spine pathology (i.e., spinal stenosis, disc herniation)
  • Other musculoskeletal co-morbidities overriding the hip-related symptoms and dysfunction
  • Co-morbidities excluding physical activity and training
  • Psycho-social disorders
  • Drug abuse
  • Not understanding the language of interest.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
58 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Changes in the Copenhagen Hip and Groin Outcome Score (HAGOS)

    Patient reported outcome regarding hip dysfunction, which includes six subscales; pain, symptoms, physical function in daily living, physical function in sport and recreation, participation in physical activity, and quality of life. The score for each subscale ranges from 0-100, where 0 indicates extreme problems and 100 no problems. Patient Acceptable Symptom State (PASS) will be derived from HAGOS score using previously described cut-off values for the different subscales

    Time frame: 3 and 7 years after baseline (cross-sectional study)

Secondary outcomes

  1. HSAS - Hip Sports Activity Scale (HSAS)

    Patient reported outcome regarding activity level. The scale ranges från 0-8 where 0 indicates the lowest activity and 8 the highest.

    Time frame: 3 and 7 years after baseline (cross-sectional study)

  2. K-10 questionnaire

    Patient reported outcome regarding mental health. This instrument consists of 10 questions, where each question is scored from 1 to 5. The total score is summerized and ranges from 10 to 50, where 10 indicates no problem and 50 severe problems.

    Time frame: 3 years after baseline (cross-sectional study)

  3. Self-Presentation in Exercise Questionnaire (SPEQ)

    Patient reported outcome regarding self image during exercise and consists of 14 questions. Each question is assessed on a 6-point Likert-type scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores represent a greater desire to present oneself as an exerciser and a greater use of strategies to portray oneself as an exerciser.

    Time frame: 3 years after baseline (cross-sectional study)

  4. The Multidimensional Scale of Perceived Social Support (MSPSS)

    The Multidimensional Scale of Perceived Social Support (MSPSS) is designed to measure perceptions of support from 3 sources: Family, Friends, and a Significant Other. The scale is comprised of a total of 12 items, with 4 items for each subscale. The items are scored on 7 point likert scale anging from 1 (very strongly disagree) to 7 (very strongly agree). The mean value tor each subscale are calculated. High score indicates a percetion of good social support.

    Time frame: 3 years after baseline (cross-sectional study)

  5. Medical Outcomes Study short form 36 (SF-36)

    Patient reported outcome regarding general health, which includes eight subscales; vitality, physical functioning, bodily pain, general health perception, physical role functioning, emotional role functioning, social role functioning and mental health. The score for each subscale ranges from 0-100, where 0 indicates extreme problems and 100 no problems.

    Time frame: 3 and 7 years after baseline (cross-sectional study)

  6. Additional questions regarding treatment, medication, patient satisfaction and perceived change in hip function.

    Additional questions about treatment, medication, patient satisfaction and perceived change in hip function will be included for descriptive purpose.

    Time frame: 3 and 7 years after baseline (cross-sectional study)

Other outcomes

  1. Imaging

    Plain radiographs with an anterior-posterior projection and Dunn-projection to evaluate hip morphology and detect possible signs of osteoarthrosis.

    Time frame: 7 years after baseline

06

Study locations

1 site
  • Department of Health Sciences, Lund University
    Lund, 22100, Sweden
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03490071
Lead sponsor
Lund University
Responsible party
Sponsor
First posted
Apr 6, 2018
Start date
Jan 1, 2018
Primary completion
Mar 1, 2024
Completion
Dec 31, 2024
Last update
Apr 15, 2026

Study contacts

Eva Ageberg, PhD
principal investigator · Lund University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion